DRTS
Alpha Tau Medical·NASDAQ
--
--(--)
--
--(--)
5.13 / 10
Netural
Analyst coverage is limited to two institutions but is overwhelmingly bullish (Strong Buy, 100% of ratings). Sentiment score is neutral, yet fund-flow evaluation is positive (7.58/10) with net inflows in block, small, medium, and large categories—only extra-large shows a slight outflow. This combination suggests institutional money is accumulating shares despite neutral price action, potentially providing downside support if macro conditions improve.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-11-24
InstitutionHC Wainwright & Co.
Times predicted5
Historical Win Rate60.0%
What is the analyst consensus for DRTS?
- DRTS holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.13/10 (Netural).
